BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2007
View Archived Issues
Positive preclinical profile of the CRF1 antagonist MTIP in animal models of alcoholism
Read More
Nycomed restructures following Altana Pharma acquisition
Read More
MerLion and Merck Banyu enter new drug discovery alliance
Read More
VASTox acquires DanioLabs and Dextra Laboratories
Read More
Pain Therapeutics in-licenses new technology for treatment of hemophilia
Read More
Results from phase I study of AEOL-10150
Read More
Dll4 as a novel target for antiangiogenic drugs
Read More
Affirmative preclinical profile set BEZ-235 for clinical evaluation
Read More
Nilvadipine show positive preliminary results in Alzheimer's
Read More
Quinvaxem vaccinations in Ethiopia
Read More
Amira raises funding to advance drug candidates through proof of concept
Read More
New WHO guidance on pneumococcal vaccines in developing countries
Read More
NovaDel Pharma outlines 2007 goals
Read More
Hana Biosciences provides pipeline update
Read More
New treatment options for metabolic disorders are disclosed in patent literature
Read More
Novel therapeutic strategies for the treatment of infection described in recent patents
Read More
Synosis Therapeutics changes name to Synosia Therapeutics
Read More
Eisai granted rights to Eril in Korea
Read More
Genta expects negative European opinion for Genasense in advanced melanoma
Read More
EAU's new guidelines recommend Sutent in first-line metastatic RCC
Read More
Revlimid recommended for approval in E.U. for multiple myeloma
Read More
Altargo recommended for E.U. approval
Read More
E.U. recommends approval of Herceptin for new breast cancer indication
Read More
Januvia approved in E.U. for type 2 diabetes
Read More
Roche files sNDA for XELOX in metastatic colorectal cancer
Read More
A-620223 a potent inhibitor of poly(ADP-ribose) polymerase
Read More
GlaxoSmithKline identifies GSK-983 as potential human papillomavirus treatment
Read More